Redwood Scientific Technologies, Inc. (RSCI)
OTC
Healthcare
Medical - Pharmaceuticals
$0.01
▲ +0.00%
Market Cap
$1,872
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Beta
-3.03
52-Wk Range
0.0001-0.07
CEO
Jason Cardiff
Country
US
Currency
USD
Redwood Scientific Technologies, Inc. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Claremont, CA, US. The stock last traded at $0.01, up 0.00% on the session, giving a market capitalisation of $1,872. On trailing twelve-month figures it carries a trailing P/E of -0.62, a net margin of 0.0%. Its beta of -3.03 implies it has historically moved less than the broad market.
Valuation & profitability (TTM)
P/E
-0.62
Price / Sales
0.00
Price / Book
-11.03
EV / EBITDA
0.08
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
—
Debt / equity
0.00
Current ratio
0.60
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
5
IPO date
2016-09-08
Headquarters
Claremont, CA, US
About Redwood Scientific Technologies, Inc.
Redwood Scientific Technologies, Inc. develops and markets over-the-counter FDA registered drugs through oral strip delivery technology. The company is based in Claremont, California.
Comparable companies
Redwood Scientific Technologies, Inc. is most often compared with the following Healthcare names:
More research on RSCI
Open full interactive analysis & DCF →